title: Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month.
authors.affiliation: Department of Nephrology, Friedrich-Alexander University Erlangen-Nürnberg, Germany.
authors.forename: H H
authors.initials: HH
authors.lastname: Neumayer
authors.forename: L
authors.initials: L
authors.lastname: Färber
authors.forename: P
authors.initials: P
authors.lastname: Haller
authors.forename: R
authors.initials: R
authors.lastname: Kohnen
authors.forename: A
authors.initials: A
authors.lastname: Maibücher
authors.forename: A
authors.initials: A
authors.lastname: Schuster
authors.forename: J
authors.initials: J
authors.lastname: Vollmar
authors.forename: J
authors.initials: J
authors.lastname: Waiser
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D003404:Creatinine / Q000378:metabolism; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014184:Transplantation, Homologous; D014527:Uric Acid / Q000097:blood
chemical_list: D014527:Uric Acid; D016572:Cyclosporine; D003404:Creatinine; D000410:Alanine Transaminase